HK2 and hepatocellular carcinoma: The EGFR‐P38 MAPK axis can enhance PD‐L1 expression through miR‐675‐5p and suppress HLA‐I (HLA‐ABC) expression via glycolysis‐related enzyme hexokinase 2 (HK2) in HCC (42).